Stay updated with breaking news from Don Bergstrom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lirafugratinib demonstrated clinical activity in multiple subsets of patients with FGFR2-altered solid tumors, including those with FGFR2-altered hormone receptor–positive, HER2-negative breast cancer.
35% ORR in patients with FGFR2 fusions & 40% ORR in patients with FGFR2-altered HR+/HER2- breast cancer RLY-4008 commercialization plans to focus on broader tumor agnostic opportunities Clinical...
35% ORR in patients with FGFR2 fusions (excluding CCA) & 40% ORR in patients with FGFR2-altered HR+/HER2- breast cancer
/PRNewswire/ -- Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has spread to the other parts of the body from...
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 26, 2023 /PRNewswire/ -- Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has